減壓補充品市場規模 - 按原料、型態、類別和分銷管道 - 區域展望、競爭策略和細分市場預測（~2033 年）

預計到2033年，全球減壓補充品市場規模將成長至10168.8億，年複合成長率為7.04%。

為緩解壓力而開發的錠劑旨在幫助人們控制和減輕壓力對其思想和情緒的影響。這些補充品通常由具有放鬆效果的天然成分組合而成。洋甘菊和纈草根等草本萃取物因其對神經系統的鎮靜作用而聞名。此外，海帶含有紅景天和睡茄等適應原，有助於身體適應壓力源。

圍繞 COVID-19 爆發和結束的不確定性引發了許多問題。除了其他心理健康問題外，壓力、焦慮、悲傷、憤怒和怨恨也變得越來越普遍。這場流行病擾亂了社會連結、工作和收入，導致世界各地的壓力水平不斷上升，焦慮和絕望感急劇增加。隨著心理健康問題的增加，越來越多的人正在尋求可行的緩解壓力的方法，例如補充品。

本報告調查了全球減壓補充品市場，並提供了市場概況、市場影響因素和市場機會分析、市場規模趨勢和預測、各個細分市場和地區的詳細分析、競爭格局以及主要企業。

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第4章市場動態

• 促進因素、限制因素、機會與挑戰分析
• COVID-19 對市場的影響

第5章 市場變數與展望

• SWOT分析
• PESTEL分析
• 波特五力分析
• 熱圖分析

第6章 競爭狀況

• 製造地、銷售區域、產品類型分佈
• 併購、聯盟、產品發布、合作

第7章全球減壓補充品市場：按類型

• 全球市佔率及預測
• 睡茄
• 洋甘菊
• 薰衣草
• 褪黑素
• 紅景天
• L-茶氨酸
• 其他

第8章全球減壓補充品市場：型態

• 全球市佔率及預測
• 膠囊/片劑
• 油
• 粉末
• 其他

第9章全球減壓補充品市場：按類別

• 全球市佔率及預測
• 有機產品
• 常規產品

第10章全球減壓補充品市場：按分銷管道

• 全球市佔率及預測
• 大賣場/超級市場
• 便利商店
• 藥局/藥房
• 專賣店
• 線上管道
• 其他

第11章全球減壓補充品市場預測

• 市場規模/市場佔有率

第12章全球減壓補充品市場：依成分分類

• 市場規模/市場佔有率趨勢/預測

第13章全球減壓補充品市場：型態

• 市場規模/市場佔有率趨勢/預測

第14章全球減壓補充品市場：依類別

• 市場規模/市場佔有率趨勢/預測

第15章全球減壓補充品市場：按分銷管道

• 市場規模/市場佔有率趨勢/預測

第16章全球減壓補充品市場：按地區

• 市場規模/市場佔有率趨勢/預測
• 亞太地區
• 歐洲
• 中東/非洲
• 北美洲
• 拉丁美洲

第17章 公司簡介

• Himalaya Drug Company
• Cureveda
• Natureplus
• Panchamrit
• Nutraceutical International Company
• Pharmalinea Ltd.
• Virtue Vitamins LIC
• Foresta Organics
• Ricola
• ADM
• 其他

第18章簡稱

第19章 參考鏈接

第20章 結論

第21章 研究範圍

Stress Relief Supplement Market Introduction and Overview

According to SPER market research, 'Stress Relief Supplement Market Size- By Source, By Form, By Category, By Distribution Channel- Regional Outlook, Competitive Strategies and Segment Forecast to 2033' state that the Global Stress Relief Supplement Market is predicted to reach 1016.88 Million by 2033 with a CAGR of 7.04%.

Tablets developed to alleviate stress are intended to assist people control and mitigate the effects of stress on their thoughts and emotions. These supplements are often made from a combination of natural ingredients that have relaxing properties. Herbal extracts, such as chamomile and valerian root, are known to have calming benefits on the nervous system. Additionally, comves contain adaptogens, including rhodiola and ashwagandha, which help the body adjust to stressors.

Numerous more widespread issues have emerged as a result of the COVID-19 epidemic and the uncertainty surrounding the crisis's conclusion. Together with other mental health conditions, stress, anxiety, sadness, rage, and anger are growing more prevalent. The pandemic raised stress levels worldwide as a result of disruptions to social ties, employment, and income, which sharply raised the incidence of anxiety and despair. A growing number of people are searching for doable stress-reduction techniques, like supplementation, as mental health problems increase.

Scope of the Report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period 2024-2033

Segments covered By Source, By Form, By Category, By Distribution Channel

Regions covered North America, Asia-Pacific, Latin America, Middle East & Africa and Europe

Companies Covered Himalaya Drug Company, Cureveda, Natureplus, Panchamrit, Nutraceutical International Company, Pharmalinea Ltd, Virtue Vitamins LIC, Foresta Organics, Ricola, ADM.

Global Stress Relief Supplement Market Segmentation:

By Source: Based on the Source, Global Stress Relief Supplement Market is segmented as; Ashwagandha, Chamomile, Lavender, Melatonin, Rhodiola, L-theanine, Others.

By Form: Based on the Form, Global Stress Relief Supplement Market is segmented as; Capsules & Tablets, Oils, Powder, Others.

By Category: Based on the Category, Global Stress Relief Supplement Market is segmented as; Organic, Conventional.

By Distribution Channel: Based on the Distribution Channel, Global Stress Relief Supplement Market is segmented as; Hypermarket/Supermarket, Convenience Stores, Drug Stores/Pharmacies, Speciality Stores, Online Channels, Others.

Table of Contents

1. Introduction

• 1.1. Scope of the report
• 1.2. Market segment analysis

2. Research Methodology

• 2.1. Research data source
  • 2.1.1. Secondary Data
  • 2.1.2. Primary Data
  • 2.1.3. SPER's internal database
  • 2.1.4. Premium insight from KOL's
• 2.2. Market size estimation
  • 2.2.1. Top-down and Bottom-up approach
• 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

• 4.1. Driver, Restraint, Opportunity and Challenges analysis
  • 4.1.1. Drivers
  • 4.1.2. Restraints
  • 4.1.3. Opportunities
  • 4.1.4. Challenges
• 4.2. COVID-19 Impacts of the Global Stress Relief Supplement Market

5. Market variable and outlook

• 5.1. SWOT Analysis
  • 5.1.1. Strengths
  • 5.1.2. Weaknesses
  • 5.1.3. Opportunities
  • 5.1.4. Threats
• 5.2. PESTEL Analysis
  • 5.2.1. Political Landscape
  • 5.2.2. Economic Landscape
  • 5.2.3. Social Landscape
  • 5.2.4. Technological Landscape
  • 5.2.5. Environmental Landscape
  • 5.2.6. Legal Landscape
• 5.3. PORTER's Five Forces
  • 5.3.1. Bargaining power of suppliers
  • 5.3.2. Bargaining power of buyers
  • 5.3.3. Threat of Substitute
  • 5.3.4. Threat of new entrant
  • 5.3.5. Competitive rivalry
• 5.4. Heat Map Analysis

6. Competitive Landscape

• 6.1. Global Stress Relief Supplement Market Manufacturing Base Distribution, Sales Area, Ingredients
• 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Stress Relief Supplement Market

7. Global Stress Relief Supplement Market, By Source (USD Million)

• 7.1. Global Stress Relief Supplement Market Value Share and Forecast, By Source 2024-2033
• 7.2. Ashwagandha
• 7.3. Chamomile
• 7.4. Lavender
• 7.5. Melatonin
• 7.6. Rhodiola
• 7.7. L-theanine
• 7.8. Others

8. Global Stress Relief Supplement Market, By Form (USD Million)

• 8.1. Global Stress Relief Supplement Market Value Share and Forecast, By Form 2024-2033
• 8.2. Capsules & Tablets
• 8.3. Oils
• 8.4. Powder
• 8.5. Others

9. Global Stress Relief Supplement Market, By Category (USD Million)

• 9.1. Global Stress Relief Supplement Market Size Value Share and Forecast, By Category 2024-2033
• 9.2. Organic
• 9.3. Conventional

10. Global Stress Relief Supplement Market, By Distribution Channel (USD Million)

• 10.1. Global Stress Relief Supplement Market Size Value Share and Forecast, By Distribution Channel 2024-2033
• 10.2. Hypermarket/Supermarket
• 10.3. Convenience Stores
• 10.4. Drug Stores/Pharmacies
• 10.5. Specialty Stores
• 10.6. Online Channels
• 10.7. Others

11. Global Stress Relief Supplement Market, Forecast, 2020-2033 (USD Million)

• 11.1. Global Stress Relief Supplement Market Size and Market Share

12. Global Stress Relief Supplement Market, By Source 2020-2033 (USD Million)

• 12.1. Global Stress Relief Supplement Market Size and Market Share, By Source (2020-2026)
• 12.2. Global Stress Relief Supplement Market Size and Market Share, By Source (2027-2033)

13. Global Stress Relief Supplement Market, By Form 2020-2033 (USD Million)

• 13.1. Global Stress Relief Supplement Market Size and Market Share, By Form (2020-2026)
• 13.2. Global Stress Relief Supplement Market Size and Market Share, By Form (2027-2033)

14. Global Stress Relief Supplement Market, By Category 2020-2033 (USD Million)

• 14.1. Global Stress Relief Supplement Market Size and Market Share, By Category (2020-2026)
• 14.2. Global Stress Relief Supplement Market Size and Market Share, By Category (2027-2033)

15. Global Stress Relief Supplement Market, By Distribution Channel 2020-2033 (USD Million)

• 15.1. Global Stress Relief Supplement Market Size and Market Share, By Distribution Channel (2020-2026)
• 15.2. Global Stress Relief Supplement Market Size and Market Share, By Distribution Channel (2027-2033)

16. Global Stress Relief Supplement Market, By Region, 2020-2033 (USD Million)

• 16.1. Global Stress Relief Supplement Market Size and Market Share, By Region (2020-2026)
• 16.2. Global Stress Relief Supplement Market Size and Market Share, By Region (2027-2033)
• 16.3. Asia-Pacific
  • 16.3.1. Australia
  • 16.3.2. China
  • 16.3.3. India
  • 16.3.4. Japan
  • 16.3.5. South Korea
  • 16.3.6. Rest of Asia-Pacific
• 16.4. Europe
  • 16.4.1. France
  • 16.4.2. Germany
  • 16.4.3. Italy
  • 16.4.4. Spain
  • 16.4.5. United Kingdom
  • 16.4.6. Rest of Europe
• 16.5. Middle East and Africa
  • 16.5.1. Kingdom of Saudi Arabia
  • 16.5.2. United Arab Emirates
  • 16.5.3. Rest of Middle East & Africa
• 16.6. North America
  • 16.6.1. Canada
  • 16.6.2. Mexico
  • 16.6.3. United States
• 16.7. Latin America
  • 16.7.1. Argentina
  • 16.7.2. Brazil
  • 16.7.3. Rest of Latin America

17. Company Profile

• 17.1. Himalaya Drug Company
  • 17.1.1. Company details
  • 17.1.2. Financial outlook
  • 17.1.3. Product summary
  • 17.1.4. Recent developments
• 17.2. Cureveda
  • 17.2.1. Company details
  • 17.2.2. Financial outlook
  • 17.2.3. Product summary
  • 17.2.4. Recent developments
• 17.3. Natureplus
  • 17.3.1. Company details
  • 17.3.2. Financial outlook
  • 17.3.3. Product summary
  • 17.3.4. Recent developments
• 17.4. Panchamrit
  • 17.4.1. Company details
  • 17.4.2. Financial outlook
  • 17.4.3. Product summary
  • 17.4.4. Recent developments
• 17.5. Nutraceutical International Company
  • 17.5.1. Company details
  • 17.5.2. Financial outlook
  • 17.5.3. Product summary
  • 17.5.4. Recent developments
• 17.6. Pharmalinea Ltd.
  • 17.6.1. Company details
  • 17.6.2. Financial outlook
  • 17.6.3. Product summary
  • 17.6.4. Recent developments
• 17.7. Virtue Vitamins LIC
  • 17.7.1. Company details
  • 17.7.2. Financial outlook
  • 17.7.3. Product summary
  • 17.7.4. Recent developments
• 17.8. Foresta Organics
  • 17.8.1. Company details
  • 17.8.2. Financial outlook
  • 17.8.3. Product summary
  • 17.8.4. Recent developments
• 17.9. Ricola
  • 17.9.1. Company details
  • 17.9.2. Financial outlook
  • 17.9.3. Product summary
  • 17.9.4. Recent developments
• 17.10. ADM
  • 17.10.1. Company details
  • 17.10.2. Financial outlook
  • 17.10.3. Product summary
  • 17.10.4. Recent developments
• 17.11. Others

18. List of Abbreviations

19. Reference Links

20. Conclusion

21. Research Scope